eIF4G Antibodies

Santa Cruz Biotechnology delivers a wide array of eIF4G monoclonal antibodies for research in understanding the mechanisms of protein synthesis. eIF4G Antibodies are validated for various techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). eIF4G, or eukaryotic translation initiation factor 4 gamma, plays a crucial role in the initiation of translation by serving as a scaffold for the assembly of the translation initiation complex. eIF4G interacts with other initiation factors and the mRNA cap structure, facilitating the recruitment of the ribosome to the mRNA. Given its central role in regulating protein synthesis, eIF4G is important in various cellular processes, including cell growth, proliferation, and response to stress. Understanding eIF4G function is essential for advancing knowledge in cancer research, developmental biology, and cellular stress responses. Studying eIF4G can provide insights into potential therapeutic targets for diseases involving dysregulated protein synthesis. Research using eIF4G monoclonal antibodies has revealed significant findings about translation control mechanisms in both normal and pathological conditions. Santa Cruz Biotechnology monoclonal antibodies for eIF4G enable researchers worldwide to advance scientific understanding of protein synthesis regulation and its impact on human health.